Results 161 to 170 of about 46,487 (292)
Adverse outcomes between VMAT2 and anticholinergics in tardive dyskinesia: A target trial emulation
Aim Vesicular monoamine transporter 2 (VMAT2) inhibitors have been approved for the treatment of tardive dyskinesia (TD), whereas anticholinergic agents are still widely used for this condition. This study aimed to compare the risk of major clinical adverse outcomes among patients with TD treated with VMAT2 inhibitors versus anticholinergic agents ...
Tien‐Wei Hsu +13 more
wiley +1 more source
Neuroleptic Malignant Syndrome Induced by Multiple Antipsychotics in a Patient Receiving Methadone. [PDF]
Suzuki N.
europepmc +1 more source
Abstract This article offers an alternative understanding to the therapeutic experiences of human interactions with companion species, particularly dogs and horses, through a phenomenological discussion of more‐than‐human intersubjectivity. In an ethnographic account of residents of the Central Coast, New South Wales, Australia, the lived experience of
Katherine Joy Fletcher
wiley +1 more source
Clinical Outcomes and Factors Associated with Neuroleptic Malignant Syndrome in Older Patients: A Case Control Study. [PDF]
Pewloungsawat P +2 more
europepmc +1 more source
Abstract figure legend A study described in this paper describes a new tool for hiPSC‐CM electromechanical behaviour simulations using mathematical modelling. The model enables in silico assays making drug testing quick, comprehensive and accurate. New hiPSC‐CM models can be used as a platform to integrate in vitro and in silico findings.
Milda Folkmanaite +9 more
wiley +1 more source
Clinical practice guidelines for management of schizophrenia in India: A comprehensive overview. [PDF]
Sahoo S +6 more
europepmc +1 more source
Psychotropic medication and the fetal brain
Abstract figure legend Brain region changes linked to in‐utero psychotropic exposure. Abstract Medications known to cross the blood–brain barrier (psychotropic medications) are commonly prescribed to women during pregnancy, often for the management of mental illness.
Oliver Gale‐Grant, Tomoki Arichi
wiley +1 more source
Objective Behavioral activation (BA) is an established treatment for depression in older adults, yet BA has been relatively less examined as a treatment for the negative symptoms (NS) of schizophrenia spectrum disorder (SSD). We here aimed to demonstrate the feasibility and proof‐of‐concept that BA can improve NS and function in older adults with SSD ...
Stephen F. Smagula +2 more
wiley +1 more source
Prevalence and predictors of high-dose antipsychotic therapy among adult psychiatric inpatients in Baghdad, Iraq. [PDF]
Nassr OA, Wadeea RF.
europepmc +1 more source
QTc Interval Prolongation and Associated Drug Therapy in Hospitalized Older Adults
Journal of the American Geriatrics Society, EarlyView.
Francesco Fantin +7 more
wiley +1 more source

